The LifeVest Wearable Difibrillator was named one of the five most innovative and life changing medical devices of last year, by the Medical Device Network.

Designed by the US-based firm ZOLL, the defibrillator is used for a wide range of patient conditions or situations including patients at risk of sudden cardiac arrest (SCA), following a heart attack, before or after bypass surgery or stent replacement, as well as for those with cardiomyopathy, people waiting for pacemakers or heart transplants or congestive heart failure that places them at particular risk.

Richard Packer, chair and CEO, of ZOLL said: "To receive this designation from a large and respected internet reference portal indicates that the Lifevest is gaining visibility on the international front as a standard of care. The Lifevest Wearable Defibrillator has protected more than 21,000 patients at high risk of sudden cardiac arrest."